Security Snapshot

MediWound Ltd. - Common Shares (MDWD) Institutional Ownership

CUSIP: M68830104

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
12,838,938
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • MDWD - MediWound Ltd. - Common Shares is tracked under CUSIP M68830104.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q4 2022 and Q1 2023.
  • SEC-reported value moved from $479,633 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

M68830104

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
MDWD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HOLD Alapkezelo Zrt. 8.1% +23% 1,039,954 +48% HOLD Alapkezelo Zrt. 13 Feb 2026
Rosalind Advisors, Inc. 7% 0% 912,319 0% Rosalind Advisors, Inc. 31 Dec 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
37
Latest
n/a
Rows shown
1-25 of 37
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$479,633 0
2022 Q4 36,502 $479,633 -$14,904,707 $13.14 1
2022 Q3 8,732,355 $12,156,900 +$7,886,736 $1.39 26
2022 Q2 3,060,032 $5,626,400 +$494,287 $1.84 19
2022 Q1 2,787,010 $5,545,527 -$1,735,379 $1.99 24
2021 Q4 3,655,370 $8,631,369 +$258,584 $2.36 27
2021 Q3 3,537,329 $11,810,598 -$1,010,498 $3.34 25
2021 Q2 3,555,747 $13,617,000 -$5,837,199 $3.83 23
2021 Q1 4,874,780 $26,170,480 +$652,531 $5.37 27
2020 Q4 4,815,044 $17,807,000 +$769,998 $3.70 26
2020 Q3 4,603,789 $17,306,000 +$273,265 $3.76 25
2020 Q2 4,541,601 $13,490,000 -$4,902,499 $2.97 23
2020 Q1 6,214,039 $9,756,000 -$982,416 $1.57 20
2019 Q4 6,818,630 $21,136,000 -$831,538 $3.10 23
2019 Q3 7,081,529 $22,565,000 -$2,317,194 $3.20 19
2019 Q2 7,812,066 $26,428,000 -$2,051,734 $3.38 24
2019 Q1 8,362,314 $41,812,000 +$1,415,133 $5.00 24
2018 Q4 8,111,968 $32,932,000 -$2,741,335 $4.06 21
2018 Q3 8,629,094 $53,199,185 -$1,620,579 $6.15 24
2018 Q2 8,809,937 $60,570,207 +$176,379 $6.90 19
2018 Q1 8,857,162 $46,061,156 -$153,501 $5.20 19
2017 Q4 8,889,781 $39,561,000 +$1,410,544 $4.45 22
2017 Q3 7,965,343 $42,498,000 +$14,965,316 $5.34 19
2017 Q2 5,152,069 $35,034,000 -$4,705,694 $6.80 19
2017 Q1 5,854,412 $38,639,000 -$638,538 $6.60 17
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .